Ambrx Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider-Käufe: Die Daten reichen nicht aus, um festzustellen, ob Insider in den letzten 3 Monaten mehr Aktien gekauft als verkauft haben.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 71.138 | 0,105 % |
| Private Companies | 1.465.262 | 2,16 % |
| VC/PE Firms | 3.710.412 | 5,46 % |
| Institutions | 26.229.289 | 38,6 % |
| Hedge Funds | 36.512.813 | 53,7 % |
Verwässerung von Anteilen: AMAM erst kürzlich innerhalb der letzten 12 Monate aufgeführt.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 16.688.636 | US$466.9m | -85,7 % | 72,32 % | |||
| 11.231.000 | US$314.2m | -83,8 % | 12,97 % | |||
| 4.352.689 | US$121.8m | -82,2 % | 5,04 % | |||
| 4.240.488 | US$118.6m | -84,9 % | 0,01 % | |||
| 3.710.412 | US$103.8m | 0 % | 3,17 % | |||
| 3.129.300 | US$87.6m | 0 % | 12,68 % | |||
| 2.154.700 | US$60.3m | 0 % | 0,16 % | |||
| 2.100.000 | US$58.8m | 161 % | 5,5 % | |||
| 2.070.000 | US$57.9m | -85,7 % | 2,59 % | |||
| 2.042.212 | US$57.1m | -62 % | 0,06 % | |||
| 1.474.258 | US$41.2m | -88 % | no data | |||
| 1.399.642 | US$39.2m | 0 % | no data | |||
| 1.255.148 | US$35.1m | 0 % | 0,36 % | |||
| 1.084.247 | US$30.3m | -81,2 % | no data | |||
| 1.060.000 | US$29.7m | 0 % | no data | |||
| 1.000.000 | US$28.0m | 0 % | 63,82 % | |||
| 1.000.000 | US$28.0m | 0 % | 44,62 % | |||
| 833.443 | US$23.3m | -90,1 % | 2,34 % | |||
| 501.604 | US$14.0m | 0 % | no data | |||
| 486.562 | US$13.6m | -85,7 % | 0,05 % | |||
| 475.000 | US$13.3m | -87,1 % | 6,62 % | |||
| 432.709 | US$12.1m | -86,7 % | 0,01 % | |||
| 399.648 | US$11.2m | 0 % | no data | |||
| 385.383 | US$10.8m | -80,4 % | 3,1 % | |||
| 330.949 | US$9.3m | -98 % | 0,02 % |